Current Oncology Reports

, Volume 15, Issue 6, pp 526–532 | Cite as

Sun Exposure, Sunbeds and Sunscreens and Melanoma. What Are the Controversies?

Cancer Prevention (J Cuzick, Section Editor)


The association between various measures of sun exposure and melanoma risk is quite complex to dissect as many case–control studies of melanoma included different subtypes of melanomas which are likely to be biologically different, so interpretation of the data is difficult. Screening bias in countries with high levels of sun exposure is also an issue. Now that progress is being made in the genetic subclassification of melanoma tumours, it is apparent that melanomas have different somatic changes according to body sites/histological subtypes and that UV exposure may be relevant for some but not all types of melanomas. Melanoma behaviour also points to non-sun-related risk factors, and complex gene–environment interactions are likely. As UV exposure is the only environmental factor ever linked to melanoma, it is still prudent to avoid excessive sun exposure and sunburn especially in poor tanners. However, the impact of strict sun avoidance, which should not be recommended, may take years to be apparent as vitamin D deficiency is a now a common health issue in Caucasian populations, with a significant impact on health in general.


Melanoma Sun exposure Sunbeds DNA repair ᅟ 


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41:45–60.PubMedCrossRefGoogle Scholar
  2. 2.
    Bataille V, Winnett A, Sasieni P, et al. Exposure to the sun and sunbeds and the risk of cutaneous melanoma in the UK. A case control study. Eur J Cancer. 2004;40:429–35.PubMedCrossRefGoogle Scholar
  3. 3.
    Bataille V, Boniol M, De Vries E, et al. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer. 2005;41:2141–9.PubMedCrossRefGoogle Scholar
  4. 4.
    • Olsen CM, Green AC, Zens MS, et al. Anthropometric factors and risk of melanoma in women: a pooled analysis. Int J Cancer. 2008;122:1100–8. This is a very interesting study showing the association between melanoma and height and weight.Google Scholar
  5. 5.
    Sergentianes TN, Antoniadis AG, Gogas H, et al. Obesity and risk of malignant melanoma: a meta-analysis of cohort and case–control studies. Eur J Cancer. 2013;49:642–57.CrossRefGoogle Scholar
  6. 6.
    Iles MM, Law MH, Stacey SN, et al. A variant in FTO shows an association with melanoma risk not due to BMI. Nat Genet. 2013;45:428–32.PubMedCrossRefGoogle Scholar
  7. 7.
    Speliotes E, Willer C, Berndt S, et al. Association analyses of 249,796 individuals reveal eighteen new loci associated with body mass index. Nat Genet. 2010;42:937–48.PubMedCrossRefGoogle Scholar
  8. 8.
    Bohm M, Schiller M, Luger TA. Non-pigmentary actions of alpha-melanocyte-stimulating hormone–lessons from the cutaneous melanocortin system. Cell Mol Biol. 2006;30:61–8.Google Scholar
  9. 9.
    Mountjoy K. Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes. Biochem J. 2010;428:305–24.PubMedCrossRefGoogle Scholar
  10. 10.
    Levine H, Afek A, Shamiss A, et al. Country of origin, age at migration and risk of cutaneous melanoma: a migrant cohort study of 1,100,000 Israeli men. Int J Cancer. 2013;133:486–94.PubMedCrossRefGoogle Scholar
  11. 11.
    Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma. A systematic review of epidemiological studies. Cancer Causes Control. 2001;12:69–82.PubMedCrossRefGoogle Scholar
  12. 12.
    Bataille V, Snieder H, MacGregor AJ, et al. Genetics of risk factors for melanoma: an adult twin study of nevi and freckles. J Natl Cancer Inst. 2000;92:457–63.PubMedCrossRefGoogle Scholar
  13. 13.
    Zhu G, Duffy DL, Eldridge A, et al. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet. 1999;65:483–92.PubMedCrossRefGoogle Scholar
  14. 14.
    Wachsmuth RC, Gaut RM, Barrett JH, et al. Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. J Invest Dermatol. 2001;117:348–52.PubMedCrossRefGoogle Scholar
  15. 15.
    Bataille V, Grulich A, Sasieni P, et al. The association between naevi and melanoma in populations with different sun exposure: a joint case–control study of melanoma in the UK and Australia. Br J Cancer. 1998;77:505–10.PubMedCrossRefGoogle Scholar
  16. 16.
    MacLennand R, Kelly JW, Rivers JK, et al. The Eastern Australian Childhood Naevus Study: site differences in density and size of melanocytic nevi in relation to latitude and phenotype. J Am Acad Dermatol. 2003;48:367–75.CrossRefGoogle Scholar
  17. 17.
    Fritschi L, McHenry P, Green A, et al. Naevi in childhood in Scotland and Australia. Br J Dermatol. 1994;130:590–603.CrossRefGoogle Scholar
  18. 18.
    Chang YM, Newton-Bishop JA, Bishop DT, et al. A pooled analysis of melanocytic naevus phenotype and the risk of cutaneous melanoma. Int J Cancer. 2009;124:420–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41:28–34.PubMedCrossRefGoogle Scholar
  20. 20.
    Baade PD, Green AC, Smithers BM, et al. Trends in melanoma incidence among children: possible influence of sun protection programs. Expert Anticancer Ther. 2011;11:661–4.CrossRefGoogle Scholar
  21. 21.
    Coory M, Baade P, Aitken J, et al. Trends in situ and invasive melanoma in Queensland, Australia 1982–2002. Cancer Causes Control. 2006;17:21–2.PubMedCrossRefGoogle Scholar
  22. 22.
    De Vries E, Boniol M, Dore JF, et al. Lower incidence but thicker melanomas in eastern Europe before 1992: a comparison with western Europe. Eur J Cancer. 2004;40:1045–52.PubMedCrossRefGoogle Scholar
  23. 23.
    Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102:605–13.PubMedCrossRefGoogle Scholar
  24. 24.
  25. 25.
    Whiteman DC, Bray CA, Siskind V. A comparison of the anatomic distribution of cutaneous melanoma in two different populations with different levels of sunlight: the west of Scotland and Queensland Australia 1982–2001. Cancer Causes Control. 2007;18:485–91.PubMedCrossRefGoogle Scholar
  26. 26.
    Bulliard JD, De Weck D, Fisch T, et al. Detailed distribution of melanoma and sunlight exposure: aetiological patterns from a Swiss series. Ann Oncol. 2007;18:789–94.PubMedCrossRefGoogle Scholar
  27. 27.
    Larue L, de Vuyst F, Delmas V. Modeling melanoblast development. Cell Mol Life Sci. 2013;70:1067–79.PubMedCrossRefGoogle Scholar
  28. 28.
    • Bonaventure J, Domingues MJ, Larue L. Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells. Pigment Cell Melanoma Res. 2013;26:316–25. This study illustrates the differences in behaviour of melanocytes at different body sites.Google Scholar
  29. 29.
    Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353:2135–47.PubMedCrossRefGoogle Scholar
  30. 30.
    • Bataille V, Kato BS, Falchi M, et al. Nevus size and number are associated with telomere length and represent potential markers of a reduced senescence in vivo. Cancer Epidemiol Biomarkers Prev. 2007;16:1499–502. This was the first study linking telomere biology and melanoma link via a high number of naevi.Google Scholar
  31. 31.
    Han J, Qureshi AA, Prescott J, et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 2009;129:415–21.PubMedCrossRefGoogle Scholar
  32. 32.
    Gandini S, Sera F, Cattaruzza P, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41:2040–59.PubMedCrossRefGoogle Scholar
  33. 33.
    Bataille V, Sasieni P, Grulich A, et al. Solar keratoses: a risk factor for melanoma but negative association with melanocytic naevi. Int J Cancer. 1998;78:8–12.PubMedCrossRefGoogle Scholar
  34. 34.
    Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst. 2003;95:806–12.PubMedCrossRefGoogle Scholar
  35. 35.
    Berwick M, Armstron A, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005;97:195–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Wangari-Talbot J, Chen S. Genetics of melanoma. Front Genet. 2013;3:330.PubMedCrossRefGoogle Scholar
  37. 37.
    Jiang Y, Rabbi M, Kim M, et al. UVA generates pyrimidine dimers in DNA directly. Biophys J. 2009;96:1151–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Larue L, Beerman F. Cutaneous melanoma in genetically modified animals. Pigment Cell Res. 2007;480:485–97.CrossRefGoogle Scholar
  39. 39.
    Luo C, Sheng J, Hu MG, et al. Loss of ARF sensitises transgenic BRAF600E mice to UV induced melanoma via suppression of XPC. Cancer Res. 2013;73:4337–48.PubMedCrossRefGoogle Scholar
  40. 40.
    Budden T, Bowden A. The role of altered nucleotide excision repair and UVB induced DNA damage in melanogenesis. Int J Mol Sci. 2013;14:1132–51.PubMedCrossRefGoogle Scholar
  41. 41.
    Spatz A, Giglia-Mari G, Benhamou S, et al. Association between DNA repair deficiency and high levels of p53 mutations in melanoma of xeroderma pigmentosum. Cancer Res. 2001;61:2480–6.PubMedGoogle Scholar
  42. 42.
    McCullough LE, Santella RM, Cleveland RJ, et al. Polymorphisms in DNA repair genes, recreational physical activity and breast cancer risk. Int J Cancer. 2013. doi:10.1002/ijc.28383.Google Scholar
  43. 43.
    Rapin I. Disorders of nucleotide excision repair. Handb Clin Neurol. 2013;113:1637–50.PubMedCrossRefGoogle Scholar
  44. 44.
    Dutton-Regester K, Kakavand H, Aoude LG, et al. Melanomas of unknown primary have a mutation profile consistent with cutaneous sun exposed melanoma. Pigment Cell Melanoma Res. 2013. doi:10.1111/pcmr.12153.PubMedGoogle Scholar
  45. 45.
    Yang D, Zhu Z, Wang, et al. Expression profiles analysis of pancreas cancer. 2013;17:311–7.Google Scholar
  46. 46.
    Turajlic S, Furney SJ, Lambros MB, et al. Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res. 2012;22:196–207.PubMedCrossRefGoogle Scholar
  47. 47.
    Furney SJ, Turajlic S, Stamp G, et al. Genome sequencing of mucosal melanomas reveal that they are driven by distinct mechanisms from cutaneous melanoma. J Pathol. 2013;230:261–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Boniol M, Autier P, Boyle P, et al. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ. 2012;345:e4557.CrossRefGoogle Scholar
  49. 49.
    Gamblicher T, Bader A, Vojvodic M, et al. Impact of UVA exposure on psychological parameters and circulating serotonin and melatonin. BMC Dermatol. 2002;2:6.CrossRefGoogle Scholar
  50. 50.
    Stanganelli I, Gandini S, Magi S, et al. Sunbed use among subjects at risk of melanoma: an Italian survey of the ban. Br J Dermatol. 2013;169:351–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Watson M, Holamn PM, Fox KA, et al. Preventing skin cancer through reduction of indoor tanning. Current evidence. Am J Prev Med. 2013;44:682–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Wehner MR, Shive ML, Chren MM, et al. Indoor tanning and non melanoma skin cancer: systematic review and meta-analysis. BMJ. 2012;345:e5909.PubMedCrossRefGoogle Scholar
  53. 53.
    Stern RS. PUVA Follow-Up Study. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy. J Am Acad Dermartol. 2002;66:553–62.CrossRefGoogle Scholar
  54. 54.
    Antonio C, Kosmadaki MG, Stratigos AJ, et al. Sunscreens-what is important to know. J Eur Acad Dermatol Venereol. 2008;22:1110–8.CrossRefGoogle Scholar
  55. 55.
    Green AC, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal cell and squamous cell carcinomas of the skin. A randomised controlled trial. Lancet. 1999;35:723–9.CrossRefGoogle Scholar
  56. 56.
    Van der Pols JC, Russel A, Bauer U, et al. Vitamin D status and skin cancer risk independent of time outdoors: 11 year prospective study in an Australian community. J Invest Dermatol. 2013;133:637–41.PubMedCrossRefGoogle Scholar
  57. 57.
    Green AC, Wiliams GM, Logan V, et al. Reduced melanoma incidence after regular sunscreen use. Randomized trial follow up. J Clin Oncol. 2011;29:257–63.PubMedCrossRefGoogle Scholar
  58. 58.
    Huncharek M, Kupelnick P. Use of topical sunscreens and risk of malignant melanoma: a meta-analysis of 9067 patients from 11 case–control studies. Am J Public Health. 2002;92:1173–7.PubMedCrossRefGoogle Scholar
  59. 59.
    Dennis LK, Beane Freeman LE, VanBeek MJ. Sunscreen use and the risk of melanoma. A quantitative review. Ann Intern Med. 2003;139:966–78.PubMedCrossRefGoogle Scholar
  60. 60.
    Lazovich D, Vogel RI, Berwick M, et al. Melanoma risk in relation to use of sunscreen or other protection methods. Cancer Epidemiol Biomarkers Prev. 2011;20:2582–93.CrossRefGoogle Scholar
  61. 61.
    Autier P, Dore JF, Schiffers E, et al. Melanoma and use of sunscreens. An EORTC case–control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group. 1995;61:749–55.Google Scholar
  62. 62.
    Nicol I, Gaudy C, Gouvernet J, et al. Skin protection by sunscreens is improved by explicit labeling and providing free sunscreen. J Invest Dermatol. 2007;127:41–8.PubMedCrossRefGoogle Scholar
  63. 63.
    Loden M, Beitner H, Gonzalez H, et al. Sunscreen use, controversies, challenges and regulatory aspects. Br J Dermatol. 2011;165:255–62.PubMedCrossRefGoogle Scholar
  64. 64.
    Krause M, Klit A, Blomberg Jensen M, et al. Sunscreens. Are they beneficial or health? An overview of endocrine disrupting properties of UV filters. Int J Androl. 2012;35:424–36.PubMedCrossRefGoogle Scholar
  65. 65.
    Glass D, Lens M, Swaminathan R, Spector TD, Bataille V. Pigmentation and vitamin D metabolism in Caucasians: low vitamin D serum levels in fair skin types. PLoS One. 2009;4:e6477.PubMedCrossRefGoogle Scholar
  66. 66.
    Field S, Newton Bishop JA. Melanoma and vitamin D. Mol Oncol. 2011;5:197–214.Google Scholar
  67. 67.
    Newton Bishop JA, Beswick S, Randerson-Moor J, et al. Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma. J Clin Oncol. 2009;27:5439–44.PubMedCrossRefGoogle Scholar
  68. 68.
    Nam S, Kweon SS, Choi JJ, et al. Racial ethnic differences in bone mineral density among older women. J Bone Miner Metab. 2013;31:190–8.PubMedCrossRefGoogle Scholar
  69. 69.
    Pilz S, Kienrich K, Tomaschitz A, et al. Vitamin D and cancer mortality: systematic review of prospective epidemiological studies. Anticancer Agents Med Chem. 2013;13:107–7.PubMedCrossRefGoogle Scholar
  70. 70.
    Penat Chilet M, Ibarrola- Villava M, Martin Gonzalez M, et al. Rs12512631 on the group specific complement (vitamin D-binding protein GC) implicated in melanoma susceptibility. PLoS One. 2012;8(3):e59607.CrossRefGoogle Scholar
  71. 71.
    Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome wide association study. Lancet. 2010;376:180–8.PubMedCrossRefGoogle Scholar
  72. 72.
    Beleza S, Santos AM, McEvoy B, et al. The timing of pigmentation in Europeans. Mol Biol Evol. 2013;30:24–35.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Twin Research and Genetic Epidemiology UnitKing’s CollegeLondonUK

Personalised recommendations